Anzeige
Mehr »
Lynx Broker
Login
Sonntag, 18.08.2019 Börsentäglich über 12.000 News von 605 internationalen Medien

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
Zur alten Webversion

Übersicht Suchergebnisse


ZeitNachrichten
Sprache: Alle DE EN
LeserMedien
14:11VIBROPOWER CORPORATION LIMITED: ANNOUNCEMENT IN RELATION TO REGULATORY ACTIONS BY SGX AND/OR OTHER AUTHORITIES::QUARTERLY UPDATE PURSUANT TO RULE 1313(2) OF THE LISTING MANUAL-
14:09Knesset building enlargement for 140 MKs approved-
14:08"Die EZB-Politik hilft vor allem Reichen"-
14:08Kevin O'Leary says you need to have all your debts paid off by age 45 - including your mortgage-
14:08This financial adviser shed 100 pounds, and $60,000 in debt and back taxes - here's how he did it-
14:08Government Increases Oil, Gas Bidding Round To Three Times A Year-
14:08Philippines Defense Secretary Calls for Shift of Gaming Centers-
14:08Iran Ready to Escort Seized Oil Tanker Back Home If Needed-
14:08More Political Leaders Visit AIIMS To Enquire About Arun Jaitley's Health-
14:08Sunday Strategist: Kathmandu, the Patagonia of New Zealand, Is Coming to America-
14:08Germany Says It Could Spend Extra $55 Billion If Crisis Hits-
14:08India Should Use Israeli Model Of Drip Irrigation System, Expert Suggests-
14:07Senior Teva R&D Executive Joins Cannabis Company Cannassure-
14:06Avro RJ100 bei Royal Air: Wo Swiss-Jumbolinos fröhlich weiterfliegen-
14:05Wirecard: Droht ein Kursverfall?68Es ist unbestritten, dass die Wirecard Aktie lange Zeit der Highflyer an der deutschen Börse war. Jeder Kursrückgang wurde von den Anlegern genutzt, jeder Anstieg weckte das Interesse neuer Käufer....
► Artikel lesen
14:03Weinland: Die zwei Seiten des Tourismusbooms-
13:58Do Not Bet Against Negative Rates In The U.S.-
13:58Week 34 Breakout Forecast: Short-Term Picks To Give You An Edge-
13:58Agricultural Commodities Post The August WASDE Report-
13:58AbbVie's FDA Approval For RINVOQ Sets Up First Phase Of Deployment Plan To Counter Humira Issue-
Seite:  Weiter >>